ReShape Lifesciences Inc. announced the signing of a preferred partner agreement with Hive Medical (Hive). Hive's software suite leverages AI, machine-learning, SMS, and patient self-service technology to increase patient volume.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2062 USD | -8.62% | +7.62% | -17.42% |
05-15 | ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024 |
1st Jan change | Capi. | |
---|---|---|
-17.42% | 4.84M | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+1.71% | 64.63B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Reshape Lifesciences Inc. Signs Preferred Partner Agreement with Hive Medical for Lead Optimization Software